IMDX
Insight Molecular Diagnostics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.89
−3.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -4.44x
- Price / sales
- 56.63x
- Price / cash flow
- -3.51x
Enterprise value
- Enterprise value
- $79.4M
- EV / sales
- 47.57x
- EV / EBITDA
- -1.70x
- EV / EBIT
- -1.86x
- Market cap
- $94.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026